A detailed history of Acg Wealth transactions in Amgen Inc stock. As of the latest transaction made, Acg Wealth holds 3,168 shares of AMGN stock, worth $837,904. This represents 0.16% of its overall portfolio holdings.

Number of Shares
3,168
Previous 3,292 3.77%
Holding current value
$837,904
Previous $801,000 10.86%
% of portfolio
0.16%
Previous 0.16%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022

SELL
$224.46 - $253.15 $27,833 - $31,390
-124 Reduced 3.77%
3,168 $714,000
Q2 2022

Jul 13, 2022

SELL
$230.71 - $256.74 $74,519 - $82,927
-323 Reduced 8.93%
3,292 $801,000
Q1 2022

Apr 07, 2022

SELL
$219.27 - $242.57 $29,162 - $32,261
-133 Reduced 3.55%
3,615 $874,000
Q4 2021

Jan 18, 2022

BUY
$198.88 - $227.6 $382,844 - $438,130
1,925 Added 105.6%
3,748 $843,000
Q3 2021

Nov 01, 2021

SELL
$212.27 - $248.7 $29,717 - $34,818
-140 Reduced 7.13%
1,823 $388,000
Q2 2021

Aug 06, 2021

SELL
$233.58 - $259.14 $18,919 - $20,990
-81 Reduced 3.96%
1,963 $479,000
Q1 2021

May 03, 2021

SELL
$221.91 - $258.6 $62,578 - $72,925
-282 Reduced 12.12%
2,044 $508,000
Q4 2020

Feb 02, 2021

BUY
$216.38 - $257.67 $7,356 - $8,760
34 Added 1.48%
2,326 $535,000
Q3 2020

Nov 12, 2020

SELL
$234.65 - $260.95 $10,089 - $11,220
-43 Reduced 1.84%
2,292 $582,000
Q2 2020

Oct 07, 2020

SELL
$197.81 - $242.74 $42,529 - $52,189
-215 Reduced 8.43%
2,335 $551,000
Q1 2020

Oct 07, 2020

SELL
$182.24 - $241.7 $135,222 - $179,341
-742 Reduced 22.54%
2,550 $517,000
Q4 2019

Feb 13, 2020

SELL
$189.21 - $243.2 $28,003 - $35,993
-148 Reduced 4.3%
3,292 $794,000
Q3 2019

Oct 30, 2019

SELL
$174.11 - $208.62 $87,577 - $104,935
-503 Reduced 12.76%
3,440 $666,000
Q2 2019

Aug 06, 2019

SELL
$166.7 - $195.41 $294,058 - $344,703
-1,764 Reduced 30.91%
3,943 $727,000
Q1 2019

Apr 25, 2019

SELL
$180.87 - $203.88 $384,529 - $433,448
-2,126 Reduced 27.14%
5,707 $1.08 Million
Q4 2018

Jan 14, 2019

SELL
$178.4 - $208.25 $11,774 - $13,744
-66 Reduced 0.84%
7,833 $1.53 Million
Q3 2018

Oct 09, 2018

SELL
$185.29 - $208.89 $183,807 - $207,218
-992 Reduced 11.16%
7,899 $1.64 Million
Q2 2018

Jul 26, 2018

BUY
$166.05 - $186.51 $111,917 - $125,707
674 Added 8.2%
8,891 $1.64 Million
Q1 2018

Apr 10, 2018

SELL
$169.43 - $198.0 $218,903 - $255,816
-1,292 Reduced 13.59%
8,217 $1.4 Million
Q4 2017

Feb 08, 2018

SELL
$168.79 - $188.59 $113,258 - $126,543
-671 Reduced 6.59%
9,509 $1.65 Million
Q3 2017

Nov 07, 2017

SELL
$167.29 - $191.0 $506,888 - $578,730
-3,030 Reduced 22.94%
10,180 $1.9 Million
Q2 2017

Aug 14, 2017

BUY
N/A
13,210
13,210 $2.28 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Acg Wealth Portfolio

Follow Acg Wealth and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acg Wealth, based on Form 13F filings with the SEC.

News

Stay updated on Acg Wealth with notifications on news.